Author(s): Pande Putu Rangga Raditya, I Dewa Gede Ugrasena, Puspa Wardhani

Email(s): puspa-w-2@fk.unair.ac.id

DOI: 10.52711/0974-360X.2022.00790   

Address: Pande Putu Rangga Raditya1, I Dewa Gede Ugrasena2, Puspa Wardhani3*
1Clinical Pathology Specialization Programme, Department of Clinical Pathology, Faculty of Medicine, Airlangga University, Dr. Soetomo Hospital, Surabaya, Indonesia.
2Departement of Pediatrics, Faculty of Medicine, Airlangga University, Dr. Soetomo Hospital, Surabaya, Indonesia.
3Department of Clinical Pathology, Faculty of Medicine, Airlangga University, Dr. Soetomo Hospital, Surabaya, Indonesia.
*Corresponding Author

Published In:   Volume - 15,      Issue - 10,     Year - 2022


ABSTRACT:
This was observational research with cross sectional type of study conducted from January to October 2020 at Dr. Soetomo General Hospital, Surabaya. The subjects of the research were 30 children’s patients with febrile neutropenic episodes with malignancy based on the criteria of the American Society of Clinical Oncology and Infectious Disease Society of America, which were grouped into 2 groups based on blood culture results from secondary data. The control group was hemophilia patients without any complaint. The presepsin level was checked using ELISA. The differences in presepsin levels in positive and negative blood cultures and the control were analyzed using T2 free samples or Mann-Whitney U according to the data distribution. Median (min-max) presepsin levels in positive, negative and control cultures: 4.1(0.3 - 14) ng/mL, 2.95(0.2 - 13.8) ng/mL, 0.1(0.1 - 0.5)ng/mL. There is no significant difference in presepsin levels between positive and negative blood culture (p = 0.606). There is a significant difference between positive and negative culture presepsin levels towards controls (p = 0.001 and p = <0.001). There is an increase in the level of presepsin in febrile neutropenic pediatric patients with malignancy, but this examination cannot differentiate between bacteremia and non-bacteremia infections.


Cite this article:
Pande Putu Rangga Raditya, I Dewa Gede Ugrasena, Puspa Wardhani. Presepsin Levels in Positive and Negative Blood Cultures of Febrile Neutropenic Pediatric Patients with Malignancies in Dr. Soetomo General Hospital, Surabaya, Indonesia. Research Journal of Pharmacy and Technology 2022; 15(10):4705-8. doi: 10.52711/0974-360X.2022.00790

Cite(Electronic):
Pande Putu Rangga Raditya, I Dewa Gede Ugrasena, Puspa Wardhani. Presepsin Levels in Positive and Negative Blood Cultures of Febrile Neutropenic Pediatric Patients with Malignancies in Dr. Soetomo General Hospital, Surabaya, Indonesia. Research Journal of Pharmacy and Technology 2022; 15(10):4705-8. doi: 10.52711/0974-360X.2022.00790   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-10-63


REFERENCES:
1.    Baraka A, Zakaria M. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies. Int J Hematol. 2018; 108(2): 184–91. doi: 10.1007/s12185-018-2447-x
2.    Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA. Executive summary: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011; 52(4): 427–31. doi: 10.1093/cid/cir073
3.    Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M. Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol. 2016; 27: 111–8. doi: 10.1093/annonc/mdw325.
4.    Raditya PPR, Ansori ANM, Notopuro PB. Immune-related Pancytopenia: A Rare Case Report in Surabaya, Indonesia. Biochemical and Cellular Archives. 2021; 21(1): 881-884.
5.    van der Galiën HT, Loeffen EAH, Miedema KGE, Tissing WJE. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia. Support Care Cancer. 2018; 26(11): 3819–26. doi: 10.1007/s00520-018-4249-3
6.    Neemann K, Yonts AB, Qiu F, Simonsen K, Lowas S, Freifeld A. Blood cultures for persistent fever in neutropenic pediatric patients are of low diagnostic yield. J Pediatric Infect Dis Soc. 2016; 5(2): 218–21. doi: 10.1093/jpids/piu145
7.    Samudra D, Prawiro SR, Santoso S, Asmoro AA, Khotimah H, Ansori ANM, Sabdoningrum EK. Therapeutic effect of statins and LPS antibody on proinflammatory mediator and biochemical markers of sepsis rat model induced by E. coli. Indian J Forensic Med Toxicol. 2020; 14(3): 1852-18. doi: 10.37506/ijfmt.v14i3.10687
8.    Arai Y, Mizugishi K, Nonomura K, Naitoh K, Takaori-Kondo A, Yamashita K. Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother. 2015; 21(8): 564-9. doi: 10.1016/j.jiac.2015.04.011
9.    Pérez GB, Calaf GM, Villalba MTM, Prieto KS, Burgos FC. Frequency of hematologic malignancies in the population of Arica, Chile. Oncol Lett. 2019; 18(5): 5637-5643. doi: 10.3892/ol.2019.10858
10.    Scheer CS, Fuchs C, Gründling M, Vollmer M, Bast J, Bohnert JA. Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study. Clin Microbiol Infect. 2019; 25(3): 326–31. 10.1016/j.cmi.2018.05.016
11.    Flayhart D, Borek AP, Wakefield T, Dick J, Carroll KC. Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics. J Clin Microbiol. 2007; 45(3): 816–21. doi: 10.1128/JCM.02064-06
12.    Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012; 18(6): 891-7. doi: 10.1007/s10156-012-0435-2
13.    Korpelainen S, Intke C, Hämäläinen S, Jantunen E, Juutilainen A, Pulkki K. Soluble CD14 as a diagnostic and prognostic biomarker in hematological patients with febrile neutropenia. Dis Markers. 2017; 2017: 9805609. doi: 10.1155/2017/9805609
14.    Widyananda MH, Pratama SK, Samoedra RS, Sari FN, Kharisma VD, Ansori ANM, Antonius Y. Molecular docking study of sea urchin (Arbacia lixula) peptides as multi-target inhibitor for non-small cell lung cancer (NSCLC) associated proteins. J Pharm Pharmacogn Res. 2021; 9(4): 484- 496.
15.    Dubey RD, Ahmad AR, Paroha S, Sahu PK, Verma S, Daharwal SJ, Prasad Reddy SLN, Qureshi MS. A New Profile of Therapeutic Potential and Toxicities of Antineoplastic Drugs. Res J Pharmacol Pharmacod. 2010; 2(6): 370-375.
16.    Hula YF. Relative risk of Hepatitis Occurrence in patients with Different types of Hematological Malignancies. Res J Pharm Tech. 2019; 12(7): 3462-3466. doi: 10.5958/0974-360X.2019.00586.9
17.    Mohammed KH, Mowafaq MG, Bassam FM, Qutaiba AIAKA. Clinical adverse effects of Chemotherapy protocolusing 6- Mercaptopurine in Iraqi patients with Acute Lymphocytic Leukemia during Maintenance Phase. Res J Pharm Tech. 2019; 12(12): 5757-5764. doi: 10.5958/0974-360X.2019.00997.1
18.    Chandanashree KS, Janet J, Shweta S, Samuel GGP. Utilization Study of Antibiotics in Febrile Neutropenic Cancer patients with Bacteraemia. Res J Pharm Tech. 2020; 13(8):3765-3770. doi: 10.5958/0974-360X.2020.00666.6
19.    Maheshwari P, Manimekalai P, Anuja P, Abuk B. Antibiotic Drug Utilization and Evaluation in Pediatric Patients. Res J Pharm Tech. 2017; 10(8): 2704-2706. doi: 10.5958/0974-360X.2017.00480.2
20.    Chandrasekar K, Saju SJ, Zechariah BH, John JA, Sadagoban GK, Arun KP. Drug Utilization Evaluation of Aminoglycosides, Gentamicin and Amikacin: A Retrospective study in pediatric patients at secondary care public hospital. Res J Pharm Tech 2021; 14(3):1247-1250. doi: 10.5958/0974-360X.2021.00221.3
21.    Birhane H, Islam M, Mariam D, Singh V. Pharmacovigilance: Adverse Drug Reactions (ADRs) in Pediatric patients in Ethiopia. Retrospective Study. Res J Pharm Tech 2021; 14(3):1499-1506. doi: 10.5958/0974-360X.2021.00266.3

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available